1 467

Cited 9 times in

Immunohistochemical subclassification of thyroid tumors with a prominent hyalinizing trabecular pattern

DC Field Value Language
dc.contributor.author구자승-
dc.contributor.author홍순원-
dc.date.accessioned2014-12-20T16:56:40Z-
dc.date.available2014-12-20T16:56:40Z-
dc.date.issued2011-
dc.identifier.issn0903-4641-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/93674-
dc.description.abstractThe purpose of this study was to evaluate the immunohistochemical characteristics of thyroid tumors with a prominent hyalinizing trabecular pattern (TTHTP). Immunohistochemical stains for thyroid transcription factor 1 (TTF-1), thyroglobulin, CD56, cytokeratin (CK) 19, galectin-3, and Ki-67 were performed on 16 cases of TTHTP. All TTHTPs were positive for TTF-1 and thyroglobulin, and nine cases expressed CD56 and Ki-67. Of these nine cases, seven satisfied the strict criteria of Carney, and four cases were positive for CK19 or/and galectin-3 and negative for Ki-67 and CD56. The remaining three cases had no Ki-67, CD56, CK19 or galectin-3 expression. All TTHTPs meeting the criteria of Carney were hyalinizing trabecular tumors (HTT), and TTHTPs which did not satisfy the criteria of Carney were subclassified according to the immunohistochemical results as the HTT type [Ki-67 (+) and CD56 (+)], papillary thyroid carcinoma (PTC) type [CK19 or galectin-3 (+)/Ki-67 (-) and CD56 (-)], or null type [Ki-67 (-), CD56 (-), CK19 (-) and galectin-3 (-)]. TTHTPs with typical histologic features and/or with typical immunohistochemical manifestations can be categorized as HTT, and the remaining TTHTPs should be categorized as the PTC or null type.-
dc.description.statementOfResponsibilityopen-
dc.format.extent529~536-
dc.relation.isPartOfAPMIS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdenoma/classification*-
dc.subject.MESHAdenoma/metabolism-
dc.subject.MESHAdenoma/pathology-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHCD56 Antigen/metabolism-
dc.subject.MESHFemale-
dc.subject.MESHGalectin 3/metabolism-
dc.subject.MESHHumans-
dc.subject.MESHImmunohistochemistry-
dc.subject.MESHKeratin-19/metabolism-
dc.subject.MESHKi-67 Antigen/metabolism-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNuclear Proteins/metabolism-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHThyroglobulin/metabolism-
dc.subject.MESHThyroid Neoplasms/classification*-
dc.subject.MESHThyroid Neoplasms/metabolism-
dc.subject.MESHThyroid Neoplasms/pathology-
dc.subject.MESHThyroid Nuclear Factor 1-
dc.subject.MESHTranscription Factors/metabolism-
dc.subject.MESHYoung Adult-
dc.titleImmunohistochemical subclassification of thyroid tumors with a prominent hyalinizing trabecular pattern-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.contributor.googleauthorSARAH LEE-
dc.contributor.googleauthorSOONWON HONG-
dc.contributor.googleauthorJA SEUNG KOO-
dc.identifier.doi10.1111/j.1600-0463.2011.02762.x-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00198-
dc.contributor.localIdA04411-
dc.relation.journalcodeJ00194-
dc.identifier.eissn1600-0463-
dc.identifier.pmid21749453-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1111/j.1600-0463.2011.02762.x/abstract-
dc.subject.keywordHyalinizing trabecular tumor-
dc.subject.keywordimmunohistochemistry-
dc.subject.keywordthyroid-
dc.contributor.alternativeNameKoo, Ja Seung-
dc.contributor.alternativeNameHong, Soon Won-
dc.contributor.affiliatedAuthorKoo, Ja Seung-
dc.contributor.affiliatedAuthorHong, Soon Won-
dc.contributor.affiliatedAuthor구자승-
dc.rights.accessRightsnot free-
dc.citation.volume119-
dc.citation.number8-
dc.citation.startPage529-
dc.citation.endPage536-
dc.identifier.bibliographicCitationAPMIS, Vol.119(8) : 529-536, 2011-
dc.identifier.rimsid28384-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.